Esperion Appoints Benjamin O. Looker as General Counsel
ANN ARBOR, Mich., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced the appointment of Benjamin O. Looker as general counsel as of January 1, 2022.
- ANN ARBOR, Mich., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced the appointment of Benjamin O. Looker as general counsel as of January 1, 2022.
- Mr. Looker will serve as a member of the Esperion executive leadership team effective immediately.
- In his role, Mr. Looker will lead the companys legal, compliance and ethics operations.
- Mr. Looker is a highly experienced legal executive with broad pharmaceutical industry experience, and proven skill supporting clinical and commercial stage companies, and I welcome him to Esperion, said Sheldon Koenig, President and Chief Executive Officer of Esperion.